Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

11.9%

5 terminated/withdrawn out of 42 trials

Success Rate

84.8%

-1.7% vs industry average

Late-Stage Pipeline

40%

17 trials in Phase 3/4

Results Transparency

21%

6 of 28 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

Phase 4

10(31.3%)

N/A

10(31.3%)

Phase 3

7(21.9%)

Phase 1

3(9.4%)

Phase 2

2(6.3%)

32Total

Phase 4(10)

N/A(10)

Phase 3(7)

Phase 1(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (42)

Showing 20 of 42 trials

NCT03555981Not ApplicableTerminated

Early Kangaroo Mother Care in Gambian Hospitalised Unstable Neonates

Role: collaborator

NCT05357560Phase 1Active Not Recruiting

A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21

Role: collaborator

NCT06047821Active Not Recruiting

Enterics for Global Health (EFGH)

Role: collaborator

NCT00269178Phase 3Completed

Cluster Randomized Trial of Peer Health Education in Malaria in The Gambia

Role: collaborator

NCT03246230Not ApplicableCompleted

Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity

Role: collaborator

NCT03502993Completed

Personalised Risk Assessment in Febrile Illness to Optimise Real-life Management Across the European Union (PERFORM)

Role: collaborator

NCT00294580Phase 4Completed

Early Childhood Malaria Prevention With Maloprim in The Gambia

Role: collaborator

NCT05952336Unknown

Transmission of Respiratory Viruses in Households in The Gambia: a Longitudinal Cohort Study (TransVIR)

Role: lead

NCT03350048Completed

Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB

Role: collaborator

NCT03896477Phase 3Completed

Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants

Role: collaborator

NCT04053907Not ApplicableUnknown

P. Falciparum Infection Dynamics and Transmission to Inform Elimination

Role: collaborator

NCT04844905Phase 3Unknown

Adjunctive Ivermectin Mass Drug Administration for Malaria Control

Role: collaborator

NCT04232618Unknown

Point-of-care Triage Test for Active Tuberculosis

Role: collaborator

NCT03254329Unknown

Establishing Global Reference Values for Human Milk

Role: collaborator

NCT03251196Unknown

TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB

Role: collaborator

NCT02129829Completed

PROLIFICA - West African Treatment Cohort for Hepatitis B

Role: collaborator

NCT01262872Phase 2Completed

Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants

Role: collaborator

NCT02710045Not ApplicableCompleted

The Interaction Between Measles and DTP Vaccination

Role: lead

NCT02967783Not ApplicableCompleted

A Campaign-based ID fIPV Administration Trial

Role: lead

NCT00169117Not ApplicableCompleted

A Stitch in Time May Save Lives: Turning Poor Bednets Into Good Ones

Role: collaborator